French consensus on management of head and neck cancer surgery during COVID-19 pandemic
Copyright © 2020 Elsevier Masson SAS. All rights reserved..
In the context of the current pandemic, there is a need for specific advice concerning treatment of patients with Head and Neck cancers. The rule is to limit as much as possible the number of patients in order to reduce the risks of contamination by the SARS-Cov-2 virus for both patients and the caregivers, who are particularly exposed in ENT. The aim is to minimize the risk of loss of opportunity for patients and to anticipate the increased number of cancer patients to be treated at the end of the pandemic, taking into account the degree of urgency, the difficulty of the surgery, the risk of contaminating the caregivers (tracheotomy) and the local situation (whether or not the hospital and intensive care departments are overstretched).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:137 |
|---|---|
| Enthalten in: |
European annals of otorhinolaryngology, head and neck diseases - 137(2020), 3 vom: 01. Mai, Seite 159-160 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fakhry, N [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID |
|---|
| Anmerkungen: |
Date Completed 22.05.2020 Date Revised 29.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.anorl.2020.04.008 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM308882954 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM308882954 | ||
| 003 | DE-627 | ||
| 005 | 20231225132709.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.anorl.2020.04.008 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1029.xml |
| 035 | |a (DE-627)NLM308882954 | ||
| 035 | |a (NLM)32303485 | ||
| 035 | |a (PII)S1879-7296(20)30098-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fakhry, N |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a French consensus on management of head and neck cancer surgery during COVID-19 pandemic |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.05.2020 | ||
| 500 | |a Date Revised 29.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a In the context of the current pandemic, there is a need for specific advice concerning treatment of patients with Head and Neck cancers. The rule is to limit as much as possible the number of patients in order to reduce the risks of contamination by the SARS-Cov-2 virus for both patients and the caregivers, who are particularly exposed in ENT. The aim is to minimize the risk of loss of opportunity for patients and to anticipate the increased number of cancer patients to be treated at the end of the pandemic, taking into account the degree of urgency, the difficulty of the surgery, the risk of contaminating the caregivers (tracheotomy) and the local situation (whether or not the hospital and intensive care departments are overstretched) | ||
| 650 | 4 | |a Practice Guideline | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a ENT | |
| 650 | 4 | |a Head and neck cancer | |
| 650 | 4 | |a SARS-Cov-2 | |
| 700 | 1 | |a Schultz, P |e verfasserin |4 aut | |
| 700 | 1 | |a Morinière, S |e verfasserin |4 aut | |
| 700 | 1 | |a Breuskin, I |e verfasserin |4 aut | |
| 700 | 1 | |a Bozec, A |e verfasserin |4 aut | |
| 700 | 1 | |a Vergez, S |e verfasserin |4 aut | |
| 700 | 1 | |a de Garbory, L |e verfasserin |4 aut | |
| 700 | 1 | |a Hartl, D |e verfasserin |4 aut | |
| 700 | 1 | |a Temam, S |e verfasserin |4 aut | |
| 700 | 1 | |a Lescanne, E |e verfasserin |4 aut | |
| 700 | 1 | |a Couloigner, V |e verfasserin |4 aut | |
| 700 | 1 | |a Barry, B |e verfasserin |4 aut | |
| 700 | 0 | |a French Society of Otorhinolaryngology, Head and Neck Surgery (SFORL) |e verfasserin |4 aut | |
| 700 | 0 | |a French Society of Head and Neck Carcinology (SFCCF) |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European annals of otorhinolaryngology, head and neck diseases |d 2010 |g 137(2020), 3 vom: 01. Mai, Seite 159-160 |w (DE-627)NLM201398648 |x 1879-730X |7 nnns |
| 773 | 1 | 8 | |g volume:137 |g year:2020 |g number:3 |g day:01 |g month:05 |g pages:159-160 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.anorl.2020.04.008 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 137 |j 2020 |e 3 |b 01 |c 05 |h 159-160 | ||